Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males

Documenti analoghi

• Population pharmacokinetic analysis of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in patients and healthy volunteers
  di: Eunsol Yang, et al.
  Pubblicazione: (2024)
• Pioglitazone‐induced alterations of purine metabolism in healthy male subjects
  di: Jihyun Kang, et al.
  Pubblicazione: (2024)
• Assessment of Pharmacokinetics and Food Effect of AD‐109, a Novel Formulation of Rivaroxaban 18 mg
  di: Hyunwook Ryu, et al.
  Pubblicazione: (2025)
• Pharmacokinetics, pharmacodynamics and safety of oral formulation (CG‐750) of ivaltinostat, a histone deacetylase inhibitor, compared to IV formulation (CG‐745)
  di: Byungwook Kim, et al.
  Pubblicazione: (2024)
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Topical Applications of Sodium Taurodeoxycholate, a Treatment for Atopic Dermatitis
  di: Heejae Won, et al.
  Pubblicazione: (2025)